NAIYER RIZVI was named director of thoracic oncology and immunotherapeutics in medical oncology at NewYork-Presbyterian/Columbia University Medical Center.
Rizvi comes from Memorial Sloan Kettering Cancer Center, where he was an attending physician and focused on thoracic immunotherapy.
He has authored or co-authored more than 60 peer-reviewed papers, books and book chapters, and currently sits on the editorial board of OncoImmunology.
